Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of LP-005 in paroxysmal nocturnal hemoglobinuria, reporting on efficacy, safety, and pharmacokinetics; the study is active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• LP-005 Injection

Snippet

Sponsor: Longbio Pharma | Conditions: PNH - Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: ACTIVE_NOT_RECRUITING